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Abstract 
 
Background:  Deep brain stimulation of the bilateral subthalamic nucleus (STN-DBS) benefits patients 
with Parkinson’s disease (PD) who at disease advanced stage regarding the motor function. While some 
patients suffer side effects of DBS, especially neurocognitive deterioration, which could also influence 
the quality of life of both patients with PD and caregivers. However, the predictive quantitative factors 
relate to postoperative decline neurocognitive function remains unclear. The purpose of the current 
study is to investigate potential predictive factors for changes in neurocognitive functions following 
DBS. 
 Methods: Thirty-five patients (20 men, 15 women) underwent bilateral STN-DBS. Scalp 
electroencephalogram (EEG) was recorded preoperatively, at rest, in the "off" medication state. Global 
relative power in theta, alpha, and beta bands was calculated. A battery of neuropsychological tests was 
used to examine executive function, processing speed, and visuospatial function both preoperatively 
and one year later. The reliable change index was calculated for each cognitive domain to measure and 
define cognitive decline. A multivariable logistic regression analysis was performed to investigate the 
relationship between preoperative factors and cognitive outcomes.  
Results: One year after DBS, patients had significant changes in processing speed and visuospatial 
function. The theta band was chosen for analysis by using 40% as a cut-off point; increased theta band-
power refers to ≥ 40%, decreased theta band-power refers to < 40%. For baseline comparison of 
neurocognitive functions between two groups, no significant differences were found except Digit 
Symbol Coding of the Wechsler Adult Intelligence Scale III (WAIS-III). A significant deterioration in 
visuospatial function indicated in increased theta band-power group  
Using reliable change index values, lower preoperative scores on the Similarities and Object Assembly 
subtests of the WAIS-III were found to be associated with decline in visuospatial functioning. No 
baseline factors were found to be related to decreases in executive functioning or processing speed. 
Conclusion: Preoperative increases in theta band power and lower scores on the Similarities subtest 
might be predictive factors for postoperative deterioration of visuospatial function. And they may be 
useful to improve treatment strategy. 
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Introduction 
Deep brain stimulation (DBS) is an established treatment option for patients with advanced Parkinson's 
disease (PD), and to achieve an optimal improvement of motor function, it has relatively strict inclusion 
criteria [1,2]. However, side effects of DBS have also been documented, for example, the new onset 
cognitive deterioration[3], which have become an important issue.  
There are some studies previously reported the estimated incidence of dementia was 35.7~89 of 1000 
person-year after subthalamic nucleus (STN) DBS[4,5]. Impairments in neuropsychological functions 
have been found to impact everyday functioning and quality of life (QOL)[6]. Moreover, some studies 
focus on the comparison of cognitive outcomes between the two different stimulation targets, STN and 
globus pallidus interna (GPi), reported more cognitive problems in the STN group[7,8]. And a greater 
decline in processing speed and working memory in an STN-DBS group was reported by Follett et al. 
when compared with a GPi-DBS group postoperatively[9]. Meanwhile, it was suggested that when 
using GPi as stimulation target the risk of cognitive decline is lower[10]. Taken together, it was 
suggested by these data that the STN and the GPi might have different neuropsychological risk profiles. 
And it was recommended by the Congress of Neurological Surgeons guideline[11] that to use GPi 
stimulation rather than STN stimulation, if there is significant concern about cognitive decline, while 
taking into consideration other goals of the surgery. Thus, identification of preoperative predictive 
factors for cognitive deterioration following DBS became an important issue.    
Electroencephalogram (EEG) characteristics of patients with PD have been studied, it was indicated 
that many patients with PD present diffused slowing of EEG [12], and that the patients with EEG 
slowness frequently present impairment of cognitive functions[13]. However, the relationship between 
preoperative quantitative EEG measures and the changes in scores of neuropsychological tests in PD 
patients still unclear. Meanwhile, considerable evidence suggesting that patients with PD frequently 
have mild cognitive impairment (MCI)[14], even in the absence of significant cognitive decline or 
dementia[15]. Yaguez et al. reported that PD patients with mild impairment in general intellectual 
functions and list learning might be at higher risk to develop deterioration in other aspects of verbal 
memory after STN-DBS[16]. Therefore, we hypothesized that patients who show preoperative slowing 
on EEG would develop neuropsychological deterioration after DBS, and preoperative 
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neuropsychological tests might have potential to be predictive factors for cognitive decline after DBS. 
And the role of cohort difference induced by individual preoperative risk factors might be important, 
because the reported deterioration of cognitive functions was observed at a population level, Besides, 
the methodological factors also need to be taken into consideration when analysis significant change 
and predictors. Here in the present study, we aim to investigate the potential preoperative cognitive 
factors that might predict cognitive deterioration following STN-DBS. And also purpose to clarify the 
predictive potential of preoperative quantitative EEG measurement for cognitive decline after DBS.  
 
Methods 
Patient population 
In total, 35 patients (20 men, 15 women) with advanced PD were included, all of them received 
bilateral STN-DBS. The patients at advanced stage of disease, and suffering severe motor complications 
from dopaminergic medications. To standardize the patient background, the following 
inclusion/exclusion criteria were applied: (i) younger than 75 years of age; (ii) no dementia (global 
cognition evaluated at 25 points or more on the MMSE); (iii) no psychiatric problem screened by a 
psychiatrist; (iv) neuroradiologically verified, absence of vascular lesion. The median disease duration 
was 11.9 years (interquartile range (IQR) 10.4 ~15.1 years), and at the time of surgery, the median age 
was 66 years (IQR 60~68). Preoperatively, the mean MMSE score was 29.1 r 1.5, which represents a 
normal level. This retrospective study that involved only routine diagnostic procedures before and after 
surgery was approved by the Ethics Committee of Chiba University Graduate School of Medicine 
(2823). All participants provided written informed consent, obtained in the “on” medication state. 
 
Preoperative EEG recording and processing 
To investigate quantitative predictive factors, we evaluate the preoperative EEG. Scalp EEG was 
recorded according to the 10-20 International system, using a digital EEG instrument (DAE-1100, Vita 
CL02, Nihon-Kohden, Tokyo, Japan). Patients were in resting awake condition with their eyes closed 
when obtaining the preoperative EEG. The Neuroworkbench software (Nihon-Kohden, Tokyo, Japan) 
 4 
was applied to processing the data. An average electrode reference was chosen for digital re-referencing. 
Consecutive, non-overlapping 3‒5-second epochs were created and visually inspected for artifacts; 15 
epochs collected for individual files. These epochs were passed through a hamming window, and a fast 
Fourier transform (FFT) was used for processing. For analysis, approximately 75-second periods of 
data were used. Frequency bands were set as follows: delta: 1.5 ~ 3.9 Hz; theta: 4 ~ 7.9 Hz; alpha: 8 ~ 
12.9 Hz; beta: 13 ~ 30 Hz. A long-term follow-up study demonstrated that high relative theta band-
power was related to PD dementia[20]. We therefore focused on relative theta band-power in current 
study. The global relative EEG power for theta frequency band was calculated as a percentage of the 
overall summed EEG power across all chosen frequency bands (alpha, beta, theta), electrodes Fp1 and 
Fp2 were for excluded for calculation. 
 
Neuropsychological assessments 
Baseline and 12-month neuropsychological assessment were performed by utilization of a battery of 
neuropsychological tests, including the Japanese versions of the Wechsler Adult Intelligence Scale III 
(WAIS-III)[21], the Rey-Osterrieth Complex Figure Test (ROCFT)[22,23], and the Trail Making Test 
(TMT)[24-26].  
The WAIS-III consisted of 10 subtests and 2 supplemental tests, thus allows for assessing a wide range 
of cognitive abilities. TMT including TMT Part A (TMT-A) and TMT part B (TMT-B), in this study, 
we used the Japanese version of the TMT, there are two different points, firstly the TMT-B is modified 
by changing letters from the Roman alphabet into Kana (Japanese phonogram); second difference is the 
direction of the paper we used for examination was arranged side-to-side, not end-to-end as in the 
English version[26]. While for ROCFT,  it is a widely used neuropsychological test for the evaluation 
of visuospatial constructional ability and visual memory[35], the Copy task and Immediate Recall task 
were evaluated by using the 36-point scoring system[22-24] adapted by E.M Taylor (1959). The full-
scale WAIS-III scores was obtained from all patients, and we selected the subtests for evaluating the 
executive function, processing speed, and visuospatial function. 
To evaluate executive function, the Similarities subtest of the WAIS-III and TMT-B were used. The 
Similarities subtest of WAIS-III is a test that requires participants to determine how 19 pairs of items 
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are alike as the relationship between items grows more abstract. Scoring is based on the participants 
ability to describe the way that each pair of items is similar. And similarities subtest often used as a 
measure of abstract reasoning[25,27]. TMT-B is reported as a measure of set-shifting and inhibition[28-
30].  
To assess processing speed, the Digit Span and the Digit Symbol Coding subtests of the WAIS-III 
along with the TMT-A were chosen.  The Digit Symbol Coding subtest is a multifaceted test, and it was 
suggested motor skills occupied a large part of the performance on this subtest[33]. The TMT-A 
provides a baseline measurement of psychomotor speed and visual search[28-30]. 
For visuospatial function, we categorized the ROCF-Copy task, Block Design, and Matrix Reasoning 
subtest of WAIS-III for evaluation. The subtests Block Design and Matrix Reasoning of the WAIS-III 
assess visual and inductive reasoning, and visuospatial and motor skills construction, 
respectively[32,34].  
The Japanese version of the WAIS-IV was not available until 2018, therefore, we used the WAIS-III 
for neuropsychological evaluation. Neuropsychological tests were performed while patients at 
medication-on state, and with the IPGs turned on at the postoperative follow-up. 
 
Surgical Procedure 
Before the surgery, a planning procedure was performed for the surgical target and trajectory, to 
visualize the STN a preoperative magnetic resonance imaging (MRI) scan was obtained, and 
stereotactic software (Surgiplan Elekta Instruments, Stockholm, Sweden) was applied to verify 
anatomical landmarks: the anterior commissure, the posterior commissure, and the midsagittal plane 
were used to determine the coordinates for the intended STN targets. On the surgery day, patients 
received the placement of stereotactic frame (Leksell G) on the ward, subsequently transferred to get 
computed tomography (CT) scans and MR images. 
Before the patient was transferred to the operating theater, the placement of the Leksell G frame was 
performed, and CT scans and MR images were obtained. An indirect anterior commissure-posterior 
commissure (AC-PC) line based targeting was performed, the coordinates are: 4.0‒5.0 mm below the 
AC-PC line, 11.5‒13.0 mm lateral to the midline, and 2.5‒3.0 mm posterior to the AC-PC midpoint; 
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the adjustment of coordinates was done according to the red nucleus which is an internal fiducial 
marker[36], and T2-weighted images and fluid-attenuated inversion recovery (FLAIR) images were 
used to visualize the STN. During the surgery, we also obtained intraoperative microelectrode 
recordings (MER), it was performed in 1-mm steps from 10 mm above the target and confirming the 
high activity in the STN, which is usually consisted of a widening of background, high-voltage spikes, 
and cells firing, and MER ends when this activity disappears. 
The intracranial leads (Model 3387, Medtronic, Minneapolis, MN, USA) was implanted bilaterally, 
and the procedure was performed while patients under local anesthesia. Final stereotactic coordinates 
were determined based on the MER, motor benefits, and side effects. After that general anesthesia was 
administered, the electrodes were connected to implantable pulse generators (IPGs; Activa; Soletra, 
Medtronic, USA). Following surgery, on the same day we took CT scans to confirm the electrodes 
locations. One day after surgery, stimulation parameters were progressively adjusted by using the 
telemetry. To obtain optimal clinical effects, stimulation parameters were set as follows: average voltage 
2.95r 0.43 V on the right side, 2.95 r 0.56 V on the left side. Pulse width and frequency were set to 60 
Ps and 130 Hz, respectively. 
 
Statistical analyses 
Cognitive changes between pre- and post-DBS states 
The change in scores between baseline and the 12-month follow-up were calculated for each test by 
subtracting individual preoperative scores from postoperative scores. Comparison of mean scores of 
neuropsychological tests between preoperative and postoperative states were performed by the use of 
Wilcoxon test, and the level of significance for all tests was set at 0.05. The effect size (mean Testbaseline 
– mean Testfollow-up /SD TestChange scores) was calculated to evaluate the magnitude of treatment effect, 
where mean Testbaseline and mean Testfollow-up refer to mean scores at baseline and 12-month follow-up 
time-point, and SD TestChange scores refers to standard deviation of difference scores. An effect size of 0.2 
-0.49 reflects a small effect, 0.5 to 0.79 a moderate, and t 0.8 a large effect[37]. 
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Quantitative EEG analyses 
Power spectrum analysis was performed to assess the relationship between the results of the 
neurocognitive tests and preoperative EEG. To evaluate postoperative The changes of scores were 
calculated by subtracting the individual baseline scores from postoperative scores. All data are 
presented as means and SD. The student t-test (two-tailed) was used for paired samples, and the level 
of significance for all tests was set at 0.05. 
 
Neuropsychological predictive factors analysis 
  To investigate predictive factors for cognitive decline after STN-DBS by using baseline parameters. 
We first calculated reliable change index (RCI) of cognitive tests for each cognitive domain, executive 
function, processing speed and visuospatial function. RCI is a statistic developed to assess change of 
individual patient, which allows for observing performance across time accounting for changes due to 
factors not related to cognitive impairments, and RCI have been utilized in some studies to capture 
individuals who may account for smaller mean group differences[17-19]. The RCI calculated with the 
formula RCI = (X2 – X1) / Sdiff, where the X1 is the patient’s baseline score, X2 is the patient’s 12-month 
score, and Sdiff is the standard error of the difference score[18,38]. A score of RCI d -1.645 was 
considered as a significant worsening on a test. In the current study, a decline was defined as a 
significant worsening of at least one of the cognitive tests that used for evaluation of the underlined 
cognitive domain based on the RCI. Wilcoxon test was utilized to screen the potential predictive factors, 
and then multivariable logistic regression analysis was then performed to investigate the relationship 
between cognitive function and preoperative factors. Analyses were performed by using JMP Ver.12 
(SAS Institute Inc., Cary, NC, USA). 
 
Results 
Motor function and medication  
A significant improvement in motor functions was demonstrated after the surgery, in the medication-
on and medication-off states, UPDRS (Unified Parkinson's Disease Rating Scale) Part III score was 
improved (medication-on state, p =0.0003; medication-off state, p < 0.0001). As for the usage of 
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dopaminergic medication, baseline Levodopa equivalent dose (LED) was reduced 1 year after the 
surgery (p < 0.0001), respectively (Table 1). 
 
Global effects of STN-DBS on neuropsychological assessments 
Table 2 shows the mean scores of preoperative and postoperative states. The mean ROCFT scores at 
baseline were slightly lower when compared with the reported normative data of the Japanese 
population[39], and as for the TMT, preoperative mean completing time was in the reported normal 
range of the same age group[26]. No significant changes indicated regarding the scores on executive 
function before and after surgery. For processing speed, significantly worsen of postoperative scores on 
Digit Symbol Coding subtest was indicated, with a small effect size. Regarding visuospatial function, 
patients showed significant poor performance on ROCFT-Copy task 1 year after STN-DBS, and effect 
size at a moderate level. 
 
EEG analyses and group assignment  
Among the 35 patients, 17 patients were able to be involved in power spectrum analysis, and we set 
them as EEG subgroup. Other patients were excluded for power spectrum analysis with the exclusion 
criteria including too many artifacts, too short of evaluation time, low level of awakeness. As we mainly 
focused on the theta band for analysis, a cut-off point (40%) was used for group assignment based on 
the mean value of theta band (43 r 15%). A theta band-power ≥ 40% (n=10) refers to the increased theta 
band-power group, while a theta band-power < 40% (n=7) refers to the decreased theta band-power 
group.  
A power spectrum analysis was performed, when comparing the preoperative scores between the 
increased theta band-power group and decreased theta band-power group, no significant difference was 
found in most of the neuropsychological tests, while only a subtest of  WAIS-III, the Digit Symbol 
Coding subtest demonstrated significant difference, significant lower score was indicated in increased 
theta band-power group (P<0.05) (Table 3). As for preoperative versus postoperative comparison of the 
changes of tests scores, the Matrix Reasoning subtest of WAIS-III, and ROCFT-Copy demonstrated 
significant differences between the two groups (Table 3). Which indicating the deterioration of 
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Visuospatial function in patients with increased theta band-power. There was no significant difference 
based on the relative theta band power in the change of executive function and processing speed.   
 
Prediction of neurocognitive change 
Thirteen patients showed decline of visuospatial function with the criterion of at least 1 significant 
RCI, while 22 patients show no change. Deterioration of visuospatial function significantly associated 
with baseline scores of Similarities subtest (no change vs. decline, 11.9 r 2.4 vs. 9.8 r 2.8, p = 0.03), 
Picture Arrangement subtest (no change vs. decline, 10.9 r 3.4 vs. 7.8 r 3.5, p = 0.03), Picture 
Completion subtest (no change vs. decline, 12.1 r 3.2 vs. 9.0 r 3.4, p = 0.01) and Object Assembly 
subtest (no change vs. decline, 10.5 r 2.6 vs. 7.6 r 2.6, p = 0.01) of WAIS-III and TMT-A (no change 
vs. decline, 67.9 r 53.5 vs. 112.8 r 67.4, p = 0.04). Cut-off values were obtained with Operating 
Characteristic curve (ROC) for Similarities subtest (cut-off point = 9, area under the curve (AUC)  = 
0.71), Picture Arrangement subtest (cut-off point = 8, AUC = 0.73), Picture Completion subtest (cut-
off point = 9, AUC = 0.73), Object Assembly subtest (cut-off point = 10, AUC = 0.79) and TMT-A (cut-
off point = 90.0, AUC = 0.71). Multivariable logistic regression analysis showed lower scores of 
preoperative Similarities (d 9, p = 0.03) and Object Assembly (d 10, p = 0.04) subtests were independent 
predictive factors for deterioration of visuospatial function (Table 4-1), while Odds ratios for 
Similarities is OR = 8.72 (95% CI, 1.04 -73.21, p = 0.046), for Object Assembly OR= 9.86 (95% CI, 
0.93 -103.98, p = 0.057). Clinical factors including age, gender, disease duration, UPDRS Part III score, 
LED, MMSE and other cognitive tests did not demonstrate significant correlation with visuospatial 
function. 
For executive function, eight patients (23%) showed a significant decline while six patients (17%) for 
processing speed based on RCI. No related preoperative factor was found with Wilcoxon analysis for 
deterioration of executive function and processing speed (not data shown).  
 
Discussion 
The present investigation focused on the predictive value of preoperative quantitative EEG and 
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baseline neuropsychological tests for cognitive decline after DBS. One year after STN-DBS, we found 
significant deterioration in visuospatial function and processing speed.  
Scalp EEG was obtained from a sub-group of patients, the results of the power spectrum analysis 
showed that preoperatively increased theta band-power correlates with the decline of visuospatial 
function one year after STN-DBS. While all patients included in the predictive factor analyzation of 
neuropsychological tests, as a result Similarities subtest and Object Assembly subtest of WAIS-III at 
baseline indicated as predictive factors for the postoperative deterioration of visuospatial function. 
 
Preoperative EEG and visuospatial function after STN-DBS  
In the EEG sub-group, Matrix Reasoning and ROCFT-Copy showed a score decline in increased theta 
band-power group (Table 3), which indicating the deterioration of visuospatial function in PD patients 
with increased relative theta band-power. Some previous studies applied quantitative EEG analyses in 
PD. It was reported that in patients with PD, a slow background rhythm frequency and increased theta 
power are potential predictive biomarkers for dementia[20]. And a study conducted by Cozac et al. 
indicated that increased theta power is associated with the development of severe cognitive decline[40]. 
These studies provide the information that, EEG slowness cloud be a risk factor for deterioration of 
cognitive function in the clinical course of PD. For patients with PD, STN-DBS leading the 
improvement of motor function, but would has negative effect on cognitive function.[41]. There is 
limited knowledge regarding the relationship of baseline EEG slowing and neurocognitive ability after 
DBS. A previous study applied the Grand Total EEG (GTE) score to evaluate preoperative and 
postoperative EEG, and using the Dem Tect and MMSE for assessment of cognitive function, they 
reported that patients with higher GTE scores preoperatively developed cognitive deterioration after 
DBS, suggesting the usefulness of preoperative GTE score for predicting postoperative cognitive 
decline[42]. However, the Dem Tect they used for cognitive evaluation could not provide detailed 
change of postoperative cognitive function, and it is reported to has higher sensitivity for dementia than 
the MMSE[43]. Based on these results by previous studies, for patients with PD and those who 
underwent STN-DBS, EEG slowing could be consider as a predictor for neurocognitive impairment. In 
the current study, preoperative EEG slowing significantly relate to the deterioration of postoperative 
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visuospatial function. The slowness of EEG might predict the vulnerability of patients to penetration of 
intracranial electrodes and stimulation. Meanwhile it might also predict the progression of visuospatial 
decline in disease natural process. It would be essential to know whether the result is consonance with 
the natural history of PD, or caused by the surgical procedure itself or the stimulation. The present 
findings might suggest visuospatial function was vulnerable in PD patients with slowness of 
preoperative EEG who treated with STN-DBS. 
 
Preoperative neuropsychological tests and visuospatial function following STN-DBS 
To evaluate predictive neuropsychological factors, we applied RCIs to define a reliable change of 
cognitive function, which showed that approximately 40% of the patients demonstrated reliable 
impairment of visuospatial function.  Then multivariable logistic regression analysis was performed 
after screening preoperative clinical factors and all available cognitive tests, results showed lower 
scores of Similarities subtest and Object Assembly subtest of WAIS-III at baseline related to the 
postoperative deterioration of visuospatial function. The Similarities subtest, as a measure of abstract 
reasoning, have been administered in some previous studies to evaluate executive function with 
different purpose[44,45]. Guzzetti et al. conducted a study that investigated the association of cognitive 
reserve with cognition and motor function in PD patients in which they indicated that cognitive reserve 
influenced the executive function and higher cognitive reserve associated with better performance on 
the WAIS Similarities subtest[45]. Cognitive reserve has been reported to contributes to the inter-
individual variability in the efficiency of standard networks, or when a brain damage has occurred the 
ability to recruit alternative resources, so that patients with greater cognitive reserve may cope better 
with brain damage than others[46], the difference in cognitive reserve may result from innate factors, 
can be significantly affected by age, and also modulated by life experience[47]. This might could be an 
explanation for our result that the patients showed poorer performance on similarities subtest before 
surgery might have a lower cognitive reserve, thus resulting deterioration of cognitive function, 
especially visuospatial function after DBS. Moreover, visuospatial skills have been primarily attributed 
to the right hemisphere[25,48,49], and many lesion studies support the right parietal lobe playing a 
fundamental role in spatial cognition[50-53]. Left hemisphere have also been reported to play an 
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important role in visuospatial task performance[54,55], as the score of Similarities subtest tended to be 
associated with left temporal lobe[56,57]. It seems visuospatial tests and Similarities subtest might not 
share anatomical correlates, considering that with the same inclusion criteria, part of the patients showed 
decline of visuospatial function after DBS, which suggesting that the vulnerability of this subgroup 
patients, and the Similarities subtest might have the potential to detect patients who might more 
sensitive to surgery and have a higher risk to develop visuospatial impairment. 
As for the Object Assembly subtest, which also identified as a predictive factor by multivariable 
logistic regression analysis, the predictive value might need to be discussed with caution. Object 
Assembly subtest, in brief, requires patients to assemble cardboard figures of familiar objects within 
the limited time. It permits the examiner to evaluate an individual's visuospatial-perceptual and visuo-
constructional skills, and patients with posterior right -hemisphere damage typically perform poorly on 
this test. The reason we did not categorize this test for the visuospatial function domain is that Object 
Assembly is an optional subtest of WAIS-III, and not to be included in the standard computations of 
summary scores[21]. Meanwhile, the Object Assembly considered correlates more highly with the 
Block Design subtest than other subtests of WAIS-III, and these tests measure very similar abilities and 
appear to be mediated by similar brain mechanisms[58]. However, statistical analysis did not reveal a 
predictive potential of the preoperative Block Design subtest for deterioration of visuospatial function. 
Since patients included in this study were PD patients at an advanced stage, suggesting that the Object 
Assembly subtest might have a higher sensitivity than the Block Design subtest in such a specific cohort 
and might have the potential to be a complementary predictive factor for visuospatial function decline. 
Further investigation with a control group would be warranted to study the generalizability of this 
finding. 
Our result is consistent with some previous studies that reported decline of visuospatial function 
following DBS[59-61]. While some studies reported no change of visuospatial function after 
surgery[17,41,62-64]. The differences in cohorts and the neuropsychological tests applied for the 
evaluation of visuospatial function might have influenced the results. Moreover, it might not be enough 
to reflect the changes in cognitive function by comparisons of mean scores of all patients between 
preoperative and postoperative states. In the current study, we applied RCI for analysis, which allows 
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for examining the influence of disease progression over time by controlling for test-retest 
reliability[38,41,64] and detect the reliable change of individual patient. 
 
Processing speed following STN-DBS 
Preoperative versus postoperative comparison of cognitive tests also demonstrated a significant 
decline of procession speed, where 6 patients showed significant RCIs. Deterioration of processing 
speed have been reported in previous studies[9,19]. The randomized, controlled study by Rothlind et al. 
comparing neuropsychological outcomes between STN and GPi and reported a slightly higher reduction 
of processing speed following STN-DBS[19]. In the current study, no baseline predictive factor was 
found regarding the decline of processing speed, whereas for decline of visuospatial function, there 
were two predictive factors identified by multivariable regression analysis, suggesting that it seems 
direct surgical effects on processing speed. The postoperative decline of processing speed might not be 
predictable using preoperative neuropsychological tests. 
Moreover, baseline comparison in EEG sub-group analysis showed significant difference of scores of 
Digit Symbol Coding subtest between increased relative theta band-power group and decreased relative 
theta band-power group. Digit Symbol Coding subtest is a measure of speeded transcription of symbols 
using a key, assessing processing speed. Burdick et al. reported that the greatest impairment was found 
on the Digit Symbol coding subtest in PD patients with a high score of MMSE[65]. In the current study, 
PD patients with a score of MMSE below 25, were not assigned to the candidate of DBS. And it has 
been reported that MMSE has low sensitivity to detect cognitive impairment including mild cognitive 
impairment[66]. In PD patients with a relatively high score on the MMSE, a wide range of cognitive 
impairment can be found [67]. The lower score of Digit Symbol Coding might indicate mild cognitive 
impairment, and the relationship of preoperative EEG slowing and the lower score suggesting the 
possibility for Digit Symbol Coding test as a potential screening method for cognitive decline in PD 
after STN-DBS. It need to be confirm with further. 
 
Limitations 
The present study has several limitations. First and most importantly, we used a small sample size 
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which would limit the generalizability of the findings. Second, lack of a control arm of PD patients, it 
has been reported that visuospatial dysfunction related to disease severity and progression[68], although 
we applied RCIs statistic to aggregate reliable declines on individual tests, a control group needed to 
clarify the effects of aging and disease progression on short-term outcomes. Third, we did not include 
an evaluation of cognitive reserve, understanding of baseline difference of patients regarding cognitive 
reserve and neurocognitive change following DBS warrant further investigation. Finally, although the 
change in visuospatial function demonstrated with statistical analyses, the subjective impact of this 
decline in patients’ daily life activities have not been recorded, further study with additional longer 
follow-up would be needed to clarify the extent of influence of such impairment to quality of life of PD 
patients. 
 
Conclusion 
An increase in preoperative EEG theta band-power, and poor preoperative performance on the 
Similarities subtest of the WAIS-III may predict deterioration of visuospatial function after STN-DBS. 
In addition, preoperative scores on the Object Assembly subtest might have the potential to be a 
complementary predictive factor. These findings extend the literature on predictive biomarkers for 
neurocognitive changes after STN-DBS and could be useful to improve patient selection, ultimately 
outcome and satisfaction.  
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